GeneHealth - Your precision medicine

Optic Disk Drusen

Disease Details

Family Health Simplified

Buy Membership

Description: Optic disk drusen are abnormal deposits of protein and calcium salts in the optic nerve head, leading to potential vision problems.
Type: Optic disk drusen is typically inherited in an autosomal dominant manner.
Signs And Symptoms: Optic disk drusen are abnormal collections of protein and calcium salts that accumulate in the optic nerve head.

**Signs and Symptoms:**
1. Often asymptomatic, especially in early stages.
2. Peripheral vision loss, though it progresses slowly.
3. Transient visual obscurations (brief episodes of vision dimming).
4. Possible optic nerve swelling.
5. Visual field defects, typically arcuate or nasal step defects.
6. Reduced visual acuity (less common and usually in later stages).
7. Visible drusen upon ophthalmic examination, which may appear as small, yellowish deposits.

Monitoring and regular eye examinations by an eye care professional are recommended to manage and observe potential progression of the condition.
Prognosis: Optic nerve damage is progressive and insidious. Some of patients will develop some peripheral field defects. These can include nasal step defects, enlarged blind spots, arcuate scotomas, sectoral field loss and altitudinal defects. Clinical symptoms correlate to visibility of the drusen. Central vision loss is a rare complication of bleeding from peripapillar choroidal neovascular membranes. Anterior ischemic optic neuropathy (AION) is a potential complication.
Onset: Optic disk drusen typically have an onset in childhood or early adolescence, although they may not be detected until later in life. These are usually discovered incidentally during an eye examination.
Prevalence: The prevalence of optic disk drusen (ODD) varies, but it is estimated to occur in approximately 0.34% to 2% of the general population. The prevalence might be higher in individuals with certain conditions such as retinitis pigmentosa.
Epidemiology: Optic disc drusen are found clinically in about 1% of the population but this increases to 3.4% in individuals with a family history of ODD. About two thirds to three quarters of clinical cases are bilateral. A necropsy study of 737 cases showed a 2.4% incidence with 2 out of 15 (13%) bilateral, perhaps indicating the insidious nature of many cases. An autosomal dominant inheritance pattern with incomplete penetrance and associated inherited dysplasia of the optic disc and its blood supply is suspected. Males and females are affected at equal rates. Caucasians are the most susceptible ethnic group. Certain conditions have been associated with disc drusen such as retinitis pigmentosa, angioid streaks, Usher syndrome, Noonan syndrome and Alagille syndrome. Optic disc drusen are not related to Bruch membrane drusen of the retina which have been associated with age-related macular degeneration.
Intractability: Optic disk drusen are not considered intractable, but they are not curable. Management focuses on monitoring and addressing any associated vision issues or complications, such as visual field loss. Regular eye exams are essential to track the condition and intervene if necessary.
Disease Severity: Optic disk drusen are typically characterized by the buildup of calcified deposits within the optic nerve head. Disease severity can vary widely:

1. **Mild:** In many cases, optic disk drusen may not cause any significant visual symptoms and are often discovered incidentally during routine eye exams.
2. **Moderate:** Some patients may experience slight visual disturbances, such as transient visual obscurations or peripheral vision loss, due to the drusen pressing on nearby structures.
3. **Severe:** In rarer cases, significant visual impairment can occur, including progressive loss of peripheral vision or even central vision loss due to complications like optic nerve atrophy or choroidal neovascularization.

It's important for patients with optic disk drusen to undergo regular eye examinations to monitor potential changes in vision or the development of complications.
Healthcare Professionals: Disease Ontology ID - DOID:13561
Pathophysiology: In children, optic disc drusen are usually buried and undetectable by fundoscopy except for a mild or moderate elevation of the optic disc. With age, the overlying axons become atrophied and the drusen become exposed and more visible. They may become apparent with an ophthalmoscope and some visual field loss at the end of adolescence. ODD can compress and eventually compromise the vasculature and retinal nerve fibers. Rarely, choroidal neovascularization may develop as the juxtapapillary nerve fibers are disrupted, with subsequent subretinal hemorrhage and retinal scarring. Even more rarely, vitreous hemorrhage may develop.
Carrier Status: Optic disk drusen are not typically associated with a carrier status as they are not primarily inherited in a straightforward Mendelian fashion. These are calcified deposits within the optic nerve head and their occurrence is often sporadic, though familial cases with a possible genetic predisposition have been noted in some instances.
Mechanism: Optic disc drusen are deposits of protein and calcium salts that accumulate in the optic nerve head.

### Mechanism:
Optic disc drusen are thought to result from abnormal axonal metabolism in the optic nerve head. These deposits are typically located anterior to the lamina cribrosa and are more commonly found in small scleral canals, potentially due to a higher predisposition for axoplasmic flow stasis. As these drusen enlarge over time, they can lead to compression and atrophy of surrounding optic nerve fibers, potentially resulting in visual field defects.

### Molecular Mechanisms:
The exact molecular mechanisms underlying optic disc drusen formation are still not entirely clear, but several factors are believed to play a role:
1. **Axonal Transport Dysfunction**: Disruption in the normal axoplasmic flow may lead to the accumulation of intracellular material.
2. **Cellular Stress and Calcium Dysregulation**: There may be an increase in localized cellular stress, leading to the concentration of calcium ions and the precipitation of calcium salts.
3. **Protein Aggregation**: Abnormal aggregation and deposition of various proteins within the optic nerve head could foster the formation of drusen. Specific proteins involved are not well-defined but are likely to include components of the extracellular matrix and stressed cellular proteins.
4. **Genetic Factors**: There is a genetic component, as the condition often runs in families. Mutations or variations in genes involved in optic nerve health and axonal transport could contribute to the development of optic disc drusen.

Research is ongoing to fully elucidate the cellular and molecular pathways involved in the formation of optic disc drusen.
Treatment: Optic disc drusen are deposits of protein-like material that accumulate in the optic nerve head. Treatment for optic disc drusen primarily involves monitoring for any associated complications, as there is no definitive cure for the drusen themselves. Regular eye examinations are essential to track any changes in vision or the optic nerve. In some cases, if complications such as choroidal neovascularization or significant vision loss occur, interventions like laser therapy, anti-VEGF injections, or surgery may be considered. The management plan should be tailored to the individual patient's needs and the progression of their condition.
Compassionate Use Treatment: Optic disk drusen (ODD) are extracellular protein and calcium deposits within the optic nerve head. Currently, there are no FDA-approved treatments specifically for ODD. However, some off-label or experimental treatments that might be considered include:

1. **Anti-VEGF Therapy:** Used in cases where there is associated choroidal neovascularization.
2. **Carbonic Anhydrase Inhibitors:** Medications like acetazolamide have been tried to reduce intraocular pressure, potentially alleviating some associated symptoms.
3. **Low Vision Aids:** Visual aids and rehabilitation can assist patients in managing vision loss.
4. **Vitamin Supplementation:** Although not a treatment, some doctors recommend antioxidants or similar supplements, although evidence is limited regarding their effectiveness.

Clinical trials may explore new avenues, and compassionate use may apply if a patient meets specific criteria and no alternatives are available. Always consult a healthcare provider for guidance tailored to individual conditions.
Lifestyle Recommendations: Optic disk drusen are deposits that can form on the optic nerve head and are often detected during routine eye exams. Here are some lifestyle recommendations for managing this condition:

1. **Regular Eye Exams:** Schedule regular check-ups with an eye specialist (ophthalmologist) to monitor the progression of optic disk drusen and check for any associated complications.

2. **Protect Your Eyes:** Wear sunglasses with UV protection to protect your eyes from harmful ultraviolet rays, which can contribute to overall eye health.

3. **Healthy Diet:** Maintain a balanced diet rich in antioxidants, such as leafy greens, fruits, and vegetables, to support eye health.

4. **Avoid Smoking:** Smoking can exacerbate eye diseases, so quitting smoking can contribute to better overall eye health.

5. **Stay Hydrated:** Ensure you are well-hydrated, as dehydration can affect the eyes and general health.

6. **Manage Systemic Health:** Conditions like hypertension or diabetes can impact eye health, so managing these conditions with the help of a healthcare provider is crucial.

7. **Monitor Symptoms:** Pay attention to any changes in vision or other symptoms like eye pain and report them to your eye doctor promptly.

8. **Exercise Regularly:** Engage in regular physical activity to improve overall health and circulation, which can indirectly benefit eye health.

Following these lifestyle recommendations can help in managing optic disk drusen and maintaining overall eye health.
Medication: There are no medications specifically available to treat optic disk drusen. Management typically involves regular monitoring of the condition through comprehensive eye examinations to track any changes in vision or the optic nerve. In some cases, treatment may focus on addressing any associated complications, such as managing elevated intraocular pressure to reduce the risk of optic neuropathy.
Repurposable Drugs: Currently, there are no specific drugs that have been repurposed for the treatment of optic disc drusen. Management primarily focuses on regular monitoring and addressing complications like visual field defects or associated vascular issues. Treatments for secondary complications, such as glaucoma, may involve medications to lower intraocular pressure.
Metabolites: Optic disk drusen are abnormal deposits of calcium and other proteins in the optic disc. Since there is no direct relationship between specific metabolites and optic disk drusen, there are no notable metabolites associated with the condition. The term ‘nan’ generally stands for "not applicable" or "not available" in this context.
Nutraceuticals: There is limited evidence supporting the use of nutraceuticals specifically for optic disc drusen. Most management focuses on regular eye examinations to monitor for complications such as vision loss or the development of complications like choroidal neovascularization. Maintaining overall eye health through a balanced diet rich in antioxidants, omega-3 fatty acids, and vitamins might be beneficial but is not a specific treatment for optic disc drusen. More research is required to establish any concrete benefits of nutraceuticals in this condition.
Peptides: Optic disk drusen are abnormal deposits of protein and calcium salts in the optic nerve head. The term "nan" does not seem to directly relate to this condition. While peptides are short chains of amino acids, there are no specific peptides primarily associated with the condition or its treatment. However, research into the pathophysiology of optic nerve head conditions sometimes involves the study of various proteins and peptides. For detailed and specific medical advice or information on treatments, consulting a healthcare provider or specialist is advisable.